Herrington CS - Search Results

1

Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma.

Ewing A, Meynert A, Churchman M, Grimes GR, Hollis RL, Herrington CS, Rye T, Bartos C, Croy I, Ferguson M, Lennie M, McGoldrick T, McPhail N, Siddiqui N, Dowson S, Glasspool R, Mackean M, Nussey F, McDade B, Ennis D, McMahon L, Matakidou A, Dougherty B, March R, Barrett JC, McNeish IA; Scottish Genomes Partnership; Biankin AV, Roxburgh P, Gourley C, Semple CA. Ewing A, et al. Among authors: herrington cs. Clin Cancer Res. 2021 Jun 1;27(11):3201-3214. doi: 10.1158/1078-0432.CCR-20-4068. Epub 2021 Mar 19. Clin Cancer Res. 2021. PMID: 33741650 Free PMC article.

2

Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer.

Smith G, Ng MT, Shepherd L, Herrington CS, Gourley C, Ferguson MJ, Wolf CR. Smith G, et al. Among authors: herrington cs. Br J Cancer. 2012 Oct 9;107(8):1327-36. doi: 10.1038/bjc.2012.410. Epub 2012 Sep 18. Br J Cancer. 2012. PMID: 22990650 Free PMC article.

3

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.

Hollis RL, Meynert AM, Churchman M, Rye T, Mackean M, Nussey F, Arends MJ, Sims AH, Semple CA, Herrington CS, Gourley C. Hollis RL, et al. Among authors: herrington cs. BMC Cancer. 2018 Jan 3;18(1):16. doi: 10.1186/s12885-017-3981-2. BMC Cancer. 2018. PMID: 29298688 Free PMC article.

4

Endocrine treatment of high grade serous ovarian carcinoma; quantification of efficacy and identification of response predictors.

Stanley B, Hollis RL, Nunes H, Towler JD, Yan X, Rye T, Dawson C, Mackean MJ, Nussey F, Churchman M, Herrington CS, Gourley C. Stanley B, et al. Among authors: herrington cs. Gynecol Oncol. 2019 Feb;152(2):278-285. doi: 10.1016/j.ygyno.2018.11.030. Epub 2018 Nov 28. Gynecol Oncol. 2019. PMID: 30501904

5

Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse.

Hollis RL, Carmichael J, Meynert AM, Churchman M, Hallas-Potts A, Rye T, MacKean M, Nussey F, Semple CA, Herrington CS, Gourley C. Hollis RL, et al. Among authors: herrington cs. Am J Obstet Gynecol. 2019 Sep;221(3):245.e1-245.e15. doi: 10.1016/j.ajog.2019.04.035. Epub 2019 May 2. Am J Obstet Gynecol. 2019. PMID: 31055034 Free PMC article.

6

High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.

Hollis RL, Churchman M, Michie CO, Rye T, Knight L, McCavigan A, Perren T, Williams ARW, McCluggage WG, Kaplan RS, Jayson GC, Oza A, Harkin DP, Herrington CS, Kennedy R, Gourley C. Hollis RL, et al. Among authors: herrington cs. Cancer. 2019 Aug 15;125(16):2772-2781. doi: 10.1002/cncr.32079. Epub 2019 Jun 2. Cancer. 2019. PMID: 31154673 Free PMC article.

7

Hormone receptor expression patterns define clinically meaningful subgroups of endometrioid ovarian carcinoma.

Hollis RL, Stanley B, Iida Y, Thomson J, Churchman M, Rye T, Mackean M, Nussey F, Gourley C, Herrington CS. Hollis RL, et al. Among authors: herrington cs. Gynecol Oncol. 2019 Nov;155(2):318-323. doi: 10.1016/j.ygyno.2019.09.001. Epub 2019 Sep 5. Gynecol Oncol. 2019. PMID: 31495455 Free PMC article.

8

Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected data.

Irodi A, Rye T, Herbert K, Churchman M, Bartos C, Mackean M, Nussey F, Herrington CS, Gourley C, Hollis RL. Irodi A, et al. Among authors: herrington cs. BJOG. 2020 Oct;127(11):1409-1420. doi: 10.1111/1471-0528.16264. Epub 2020 May 7. BJOG. 2020. PMID: 32285600

9

Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer.

Langdon SP, Herrington CS, Hollis RL, Gourley C. Langdon SP, et al. Among authors: herrington cs. Cancers (Basel). 2020 Jun 22;12(6):1647. doi: 10.3390/cancers12061647. Cancers (Basel). 2020. PMID: 32580290 Free PMC article. Review.

10

Clear cell carcinoma of the ovary: a clinical and molecular perspective.

Iida Y, Okamoto A, Hollis RL, Gourley C, Herrington CS. Iida Y, et al. Among authors: herrington cs. Int J Gynecol Cancer. 2021 Apr;31(4):605-616. doi: 10.1136/ijgc-2020-001656. Epub 2020 Sep 18. Int J Gynecol Cancer. 2021. PMID: 32948640 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters